• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Credo BS

Anonymous

Guest
Janssen leadership continues to try and impress those interviewing with the company about how great the credo is and how great jnj is....yeah right you posers!

Pharmalot: What’s your take on the J&J credo?
Jones: It’s been trashed. It’s come to represent a stark and sterling example of corporate hypocrisy. It doesn’t exist in reality. Through the whole episode, through the course of this trial, they would say that they have policies and procedures in place to guard against this sort of practice. But they ignored them. And they did so for profit. I think those were just empty words - on paper and on their building.
 

<







Want to examine J&J's need to put profits ahead of patients ... look no further...


"Blood Feud", by Kathleen Sharp

.... A True Story About Procrit, Amgen and Johnson & Johnson
 




Over the next two years JNJ needs to address unprecedented market shifts, increasing competition in key product areas and existing inefficiencies in its own organization to ensure the long-term success of its business model... SPELLS JOB cuts.
 












Similar threads

Replies
8
Views
4K
Janssen
anonymous
Replies
25
Views
4K
Janssen
anonymous
Replies
0
Views
1K
Janssen
anonymous
Replies
45
Views
14K
Janssen
anonymous